Jan Molinský

455 citations
17 papers · 200 indexed · h-index 7
Topics
Lymphoma Diagnosis and Treatment (8 papers)Cell death mechanisms and regulation (5 papers)Chronic Lymphocytic Leukemia Research (4 papers)

In The Last Decade

Jan Molinský

17 papers receiving 198 citations

Peers

Jan Molinský
Comparison fields: 5 of 42
  • Molecular Biology 113
  • Oncology 81
  • Pathology and Forensic Medicine 66
  • Genetics 55
  • Hematology 30
Replace Jennifer A. Arzt with:
Jennifer A. Arzt United States
Agata Majchrzak Poland
Dejan Radeski Australia
Toshie Ogasawara Japan
Baole Wang United States
Catalina Amador United States
Archana Dilip United States
Luca Paruzzo Italy
Abbarna A. Cumaraswamy Canada
Tobias Roider Germany
Jan Molinský relative to Jennifer A. Arzt United States Jennifer A. Arzt's profile →
Citations per field
00.5×4.3×
Jennifer A. Arzt · 1×
Citations per year

Countries citing papers authored by Jan Molinský

Since Specialization
Citations

This map shows the geographic impact of Jan Molinský's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan Molinský with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan Molinský more than expected).

Fields of papers citing papers by Jan Molinský

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jan Molinský. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan Molinský. The network helps show where Jan Molinský may publish in the future.

Co-authorship network of co-authors of Jan Molinský

This figure shows the co-authorship network connecting the top 25 collaborators of Jan Molinský. A scholar is included among the top collaborators of Jan Molinský based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jan Molinský. Jan Molinský is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
#WorkIndexed citations
1 2
2 6
3 6
4 4
5 1
6 72
7 28
8 24
9 3
10 4
11 24
12 1
13 8
14 10
15 5
16 1
17
[Wall shear stress and endothelium].
1

About Jan Molinský

Jan Molinský is a scholar working on Pathology and Forensic Medicine, Genetics and Cancer Research, having authored 17 papers that have together received 200 indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (8 papers), Cell death mechanisms and regulation (5 papers) and Chronic Lymphocytic Leukemia Research (4 papers). The work is most often cited by research in Genetics (55 citations), Pathology and Forensic Medicine (66 citations) and Oncology (81 citations). Jan Molinský has collaborated with scholars based in Czechia, United States and Slovakia. Frequent co-authors include Pavel Klener, Magdalena Klánová, Marek Trněný, Ladislav Anděra, Petra Vočková, Radek Jakša, Dana Průková, Roman Kodet, E Nečas and Karel Helman. Their work appears in journals such as Blood, Scientific Reports and Clinical Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026